Chemoinformaics analysis of 3-METHOXYICAJINE
| Molecular Weight | 394.471 | nRot | 1 |
| Heavy Atom Molecular Weight | 368.263 | nRig | 31 |
| Exact Molecular Weight | 394.189 | nRing | 7 |
| Solubility: LogS | -1.98 | nHRing | 5 |
| Solubility: LogP | 0.924 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 5 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 4 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 61.1546 |
| nHD | 0 | BPOL | 34.7114 |
| QED | 0.728 |
| Synth | 6.494 |
| Natural Product Likeliness | 1.998 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.636 |
| Pgp-sub | 0.022 |
| HIA | 0.014 |
| CACO-2 | -5.236 |
| MDCK | 0.0000335 |
| BBB | 0.976 |
| PPB | 0.271857 |
| VDSS | 2.547 |
| FU | 0.705549 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.671 |
| CYP2c19-inh | 0.042 |
| CYP2c19-sub | 0.96 |
| CYP2c9-inh | 0.024 |
| CYP2c9-sub | 0.113 |
| CYP2d6-inh | 0.005 |
| CYP2d6-sub | 0.46 |
| CYP3a4-inh | 0.254 |
| CYP3a4-sub | 0.941 |
| CL | 14.955 |
| T12 | 0.226 |
| hERG | 0.266 |
| Ames | 0.013 |
| ROA | 0.747 |
| SkinSen | 0.369 |
| Carcinogencity | 0.716 |
| EI | 0.008 |
| Respiratory | 0.927 |
| NR-Aromatase | 0.369 |
| Antiviral | Yes |
| Prediction | 0.607593 |